Document Detail


Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
MedLine Citation:
PMID:  16891009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Recent studies have demonstrated that PPARgamma ligands have anti-inflammatory effect which is involved in ventricular remodeling. So we hypothesized that PPARgamma ligand may have beneficial effects on post-infarct ventricular remodeling. METHODS: Experimental myocardial infarction (MI) was induced in SD rats by ligation of the left coronary artery. Twenty-four hours after surgery, survival rats were randomly divided into MI group and Rosiglitazone (MI+Ros) group which would take rosiglitazone 3 mg/kg day for 8 weeks. After 8 weeks treatment, left ventricular hemodynamics were measured and organs were weighed. Myocardial collagen analysis was determined in Van Gieson staining by quantitative morphometry. Myocardial angiotensin II and aldosterone were detected by radioimmunoassay. Myocardial AT1 and AT2 mRNA expression were determined by RT-PCR. RESULTS: Only 1 rat in MI group died of anesthesia at the 8th week. Rosiglitazone treatment could improve left ventricular +/-dp/dt(max), collagen volume fraction and perivascular circumferential area; reduce lung/body mass ratio and liver/body mass ratio; inhibit myocardial angiotensin II and aldosterone; and had no significant effects on myocardial AT1 and AT2 mRNA. Plasma insulin and blood glucose were comparable between two groups. CONCLUSIONS: PPARgamma ligand has neutral effect on mortality and beneficial effect on post-infarct ventricular remodeling, partly by suppressing myocardial angiotensin II and aldosterone, irrespective of plasma insulin and blood glucose level.
Authors:
Deng-feng Geng; Wei Wu; Dong-mei Jin; Jing-feng Wang; Yi-mei Wu
Related Documents :
18664019 - The influence of carvedilol on atrial connexin 40 after myocardial infarction.
14715499 - Increased susceptibility to ventricular arrhythmias in a rodent model of experimental d...
15087239 - Differential functional expression of human myocardial g protein receptor kinases in le...
12388319 - Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment.
20859279 - Using a cardiac anchor to refine myocardial infarction surgery in the rat.
14557999 - Needles to promote ventricular blood into the ischemic myocardium applied in a rat hear...
17058749 - The california cardiac surgery and intervention project: evolution of a public reportin...
9107169 - Defibrillation efficacy of commercially available biphasic impulses in humans. importan...
2350329 - Involvement of lysosome-like particles in the metabolism of endogenous myocardial trigl...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-08-07
Journal Detail:
Title:  International journal of cardiology     Volume:  113     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-11-06     Completed Date:  2007-01-04     Revised Date:  2007-02-22    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  86-91     Citation Subset:  IM    
Affiliation:
Department of Cardiology, The Second Affiliated Hospital, SUN Yat-sen University, West Yanjiang Road, Guangzhou, 510120, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone Antagonists / pharmacology
Angiotensin II / antagonists & inhibitors
Animals
Blood Glucose / metabolism
Body Weight
Collagen / metabolism
Insulin / blood
Ligands
Liver / pathology
Lung / pathology
Male
Myocardial Infarction / metabolism,  pathology,  physiopathology*
Myocardium / metabolism,  pathology
Organ Size / drug effects
PPAR gamma / metabolism*
Rats
Rats, Sprague-Dawley
Thiazolidinediones / pharmacology*
Ventricular Remodeling / drug effects*
Chemical
Reg. No./Substance:
0/Aldosterone Antagonists; 0/Blood Glucose; 0/Ligands; 0/PPAR gamma; 0/Thiazolidinediones; 11061-68-0/Insulin; 11128-99-7/Angiotensin II; 122320-73-4/rosiglitazone; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Self-management of oral anticoagulant therapy: a systematic review and meta-analysis.
Next Document:  Clinical presentation is the main predictor of in-hospital death for patients with acute type A aort...